Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just my opinion

RE: "I believe it is then and only then that PTSC will be catapulted to the highs of 2006 and give all investors a chance to cash out with a nice profit."

A nice profit? Yes, from this SP point.

To the highs of 2006? I can't make a case for that, given PTSC's terminal outlook, the declining number of potential customers (= inevitable declining license revenue), and the legal costs of proving infringement in each customer's case. Remember, even if we get a favorable ITC ruling, each case would still stand on its own merits.

So depending on the average price of our holdings, we might need to double down to make better than a nice profit. Doubling down is not without risk, but it might be a relatively low cost risk at this SP point.

Sorry, this may sound like pumping, but I have no intention of doubling down.

Share
New Message
Please login to post a reply